Choksi Laboratories Ltd.

51.45 -0.05 ▼-0.1%

23 February 2024, 04:01:00 PM
Volume: 2,787

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.choksilab.com
Market Cap 35.86 Cr.
Enterprise Value(EV) 74.97 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 4.90 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 10.51 Trailing Twelve Months Ending 2023-12
Industry PE 71.22 Trailing Twelve Months Ending 2023-12
Book Value / Share 31.07 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.66 Calculated using Price: 51.48
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.70 Cr. 6,965,263 Shares
FaceValue 10
About Choksi Laboratories Ltd.
Established in 1982, Choksi Laboratories Limited (CLL), is more widely known as a leading analysis and research group, providing complete solutions for improving quality in processes, products and services.

Choksi Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Choksi Laboratories Ltd. Performance

1 Day
-0.10%
1 Week
+1.34%
1 Month
-21.35%
3 Month
-36.55%
6 Month
-4.97%
1 Year
+19.65%
2 Year
+124.18%
5 Year
+250.0%
10 Year
+785.54%

Choksi Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 4.45 3.67 4.34 6.19 6.9 -17.57 -13.74 1.16 16.46
Return on Capital Employed (%) 9.39 7.32 8.41 10.49 10.14 -8.27 0.02 6.75 13.9
Return on Assets (%) 2.31 1.8 2.15 3.16 3.2 -6.53 -4.06 0.32 5.24

Choksi Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 19 20 21 22 24 20 18 18 21 22
Non Curr. Liab. 6 9 5 7 18 29 31 30 26 21
Curr. Liab. 12 14 14 16 13 14 16 16 13 28
Minority Int.
Equity & Liab. 38 43 41 45 55 64 65 63 59 70
Non Curr. Assets 23 28 28 30 39 47 52 49 46 46
Curr. Assets 15 15 13 15 16 17 13 14 14 24
Misc. Exp. not W/O
Total Assets 38 43 41 45 55 64 65 63 59 70

Choksi Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 22 22 29 31 34 28 26 30 34 35
Other Income 1 0 1 0 0 0 0 0 0 0
Total Income 23 22 30 32 34 28 26 30 35 35
Total Expenditure -17 -17 -24 -25 -26 -25 -22 -21 -24 -25
PBIDT 6 5 6 7 8 3 5 9 10 10
Interest -2 -1 -1 -2 -2 -2 -3 -3 -4 -3
Depreciation -3 -3 -3 -3 -4 -5 -5 -5 -6 -6
Taxation -1 0 0 -1 -1 2 0 0 -1 0
Exceptional Items -2 2 2
PAT 1 1 1 1 2 -4 -3 0 3 3
Adjusted EPS 1 1 1 2 2 -6 -4 0 5 5

Choksi Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 2 7 7 6 7 3 6 8 8
Cash Fr. Inv. -6 -1 -7 -2 -5 -10 -14 -8 -3 -1
Cash Fr. Finan. 1 -1 1 -5 -1 2 11 2 -5 -8
Net Change -1 0 0 0 0 -1 0 0 0 0
Cash & Cash Eqvt 1 1 1 1 1 0 0 0 0 0

Choksi Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 31.48 31.48 31.48 31.48 31.48 31.48 31.48 31.48 31.48
Public 68.52 68.52 68.52 68.52 68.52 68.52 68.52 68.52 68.52
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Choksi Laboratories Ltd. Announcements

Mon, 05 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
The unaudited Financial Results for the quarter and nine months ended 31.12.2023 which was approved in the Board Meeting dated 03rd February 2024 has been published in the newspaper on 04th February 2024. We are enclosing herewith the newspaper clipping of the said publications.
Sat, 03 Feb 2024
Board Meeting Outcome for Outcome Of Board Meeting Held On 03Rd February 2024
1. Considered and approved Un-audited Standalone Financial Results along with Limited Review Reports for the Quarter and Nine month ended on 31st December 2023.2. Appointment of Mrs. Prachi Mantri (DIN: 10491114) as an Additional Director of the Company in the category of the Independent Director of the Company w.e.f. 03rd of February 2024 subject to the Conformation of the Members;Mrs. Prachi Mantri was not related with any of the Present Director of the Company.3. Taken on record the sad demine of Late Mr. Nanoo Krishna Mani Independent Director of the company;4. Approve the re-appointment of Ms. Surabhi Agrawal Practicing Company Secretary as Secretarial Auditor of the Company for the Financial Year 2023-24
Sat, 03 Feb 2024
Financial Result For The Quarter And Nine Month Ended 31.12.2023
Unaudited Financial Result for the period ended 31.12.2023

Choksi Laboratories Ltd. Technical Scans

Fri, 23 Feb 2024
Close Below Last Month Low Close Below Last Month Low
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 2 Years High Increase in 2 Years
High Increase in 5 Years High Increase in 5 Years

Choksi Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,560.95 +0.2%
Cipla Ltd. 118,375.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,742.15 -0.4%
Divi's Laboratories Ltd. 96,748.70 3,636.05 -0.3%
Zydus Lifesciences Ltd. 93,335.34 922.10 +1.9%
Torrent Pharmaceuticals Ltd. 88,913.00 2,627.10 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 31.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,627.10 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 4.57 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,627.10 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,627.10 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,627.10 +0.7%

Choksi Laboratories Ltd. FAQ's

What is Choksi Lab share price?

Can I buy Choksi Lab shares now?

What is the Market Cap of Choksi Lab?

What are the key metrics to analyse Choksi Lab?

What is the 52 Week High and Low of Choksi Lab?

What is the trend of Choksi Lab share price?